OFI Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$1.7M Sell
20,265
-1,300
-6% -$110K 0.11% 177
2015
Q2
$1.8M Sell
21,565
-1,967
-8% -$150K 0.11% 191
2015
Q1
$1.71M Buy
23,532
+233
+1% +$16.6K 0.1% 201
2014
Q4
$1.61M Sell
23,299
-1,817
-7% -$123K 0.1% 191
2014
Q3
$1.63M Sell
25,116
-2,595
-9% -$164K 0.12% 174
2014
Q2
$1.72M Sell
27,711
-162
-0.6% -$9.67K 0.12% 156
2014
Q1
$1.64M Sell
27,873
-3,923
-12% -$219K 0.13% 148
2013
Q4
$1.62M Buy
31,796
+5,296
+20% +$265K 0.13% 143
2013
Q3
$1.33M Sell
26,500
-83
-0.3% -$4.34K 0.13% 149
2013
Q2
$1.31M Buy
+26,583
New +$1.45M 0.14% 143

Other funds holding LLY

OFI Advisors's LLY Position: Q3 2015 in Review

OFI Advisors reduced its Eli Lilly (LLY) stake by 6% in Q3 2015, selling an estimated $110K and leaving 20,265 shares worth $1.7M. The position accounts for 0.11% of the portfolio, ranked #177.

OFI Advisors first reported a position in LLY in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.8M in Q2 2015. 1,147 funds tracked by Wall St. Rank hold LLY as of Q3 2015.

  • OFI Advisors held 20,265 shares of Eli Lilly worth $1.7M as of Q3 2015.
  • OFI Advisors sold 1,300 Eli Lilly shares in Q3 2015, an estimated $110K.
  • Eli Lilly made up 0.11% of OFI Advisors's portfolio in Q3 2015, its #177 holding.
  • OFI Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Eli Lilly position peaked at $1.8M in Q2 2015.
  • 1,147 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.